Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 295
Selected: 0
NCT IDTitle
NCT04276376Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors
NCT00811408Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy
NCT01834950Identification of Early Markers of Response and Resistance to Trastuzumab
NCT00162708Very Intense Radiotherapy-chemotherapy Regimen in Advanced HNSCC
NCT02613962Proof -of -Concept Study To Stratify Targeted Therapies Adapted To Molecular Profiling
NCT00127621Early Tracheotomy Versus Prolonged Endotracheal Intubation in Intensive Care Unit (ICU) Patients
NCT05874063Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors
NCT01887340Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma
NCT01557114Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma
NCT06364631CARE1 Pragmatic Clinical Trial
NCT00162812Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin
NCT03609112Neurocognitive Risks in Children With Solid Tumors
NCT03010553Multicenter Phase II Study of Sentinel Node Detection in Squamous Cell Carcinoma T1-T2N0 of the Oropharynx Treated With Radiotherapy and Larynx Treated by Surgery, Laser or Robot
NCT00936156Treatment of High-Risk Cerebral Primitive Neuroectodermal Tumors in Children Aged Over 5 Years
NCT00410683Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by Surgery
NCT01459003Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer
NCT05481502An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors
NCT03246841Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.
NCT02902874Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +
NCT00127049Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors
NCT02233049Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
NCT06934057Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma
NCT00544349Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery
NCT07591493Adjuvant Trial in Pancreatic Neuroendocrine Tumors
NCT07303387Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.
NCT00005062Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission
NCT01857453Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas
NCT04270864Intratumoral Tilsotolimod, a TLR-9 Agonist, Together With Intratumoral Ipilimumab and Intravenous Nivolumab in Patients With Advanced Cancers
NCT01677884Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy
NCT02828462Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics
NCT02494973Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases
NCT00180960Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia
NCT00126230Trial of Docetaxel-samarium in Patients With Hormone-refractory Advanced Prostate Cancer
NCT07016230Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)
NCT02151214Efficacy of Parenteral Nutrition in Patients at the Palliative Phase of Cancer.
NCT01403324Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer
NCT03351296Two Chemotherapy Regimens Plus or Minus Bevacizumab
NCT07754006Preliminary Clinical Feasibility Study of a Medical Device Enabling Brain Access Using Microbubble-Enhanced Sonication
NCT04221035High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
NCT04477681Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults
NCT02369757Patients Navigator for Organized Colorectal Cancer Screening
NCT00180895Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL
NCT01801176Peripheral Primitive Fibromatosis
NCT01884922Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults
NCT04985266A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer
NCT00359645Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population
NCT05267912Prospective Multicenter Study Evaluating Feasibility and Efficacy of Tumor Organoid-based Precision Medicine in Patients With Advanced Refractory Cancers
NCT06116578Study Evaluating Pembrolizumab +/- Olaparib in TLS Positive Selected Resectable STS Followed by Adjuvant Pembrolizumab
NCT03819101Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
NCT01701479Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2)